Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

News

  1. Home>
  2. News>
  3. Page 3

Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

  • Post published:August 24, 2026
  • Post category:Knowledge

India's pharmaceutical industry supplies over 20% of the world's generic medicines by volume. For international buyers — hospitals, pharmacies, procurement agencies, and individual patients — the safety and quality of…

Continue Reading Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

Indian Pharma’s $250B 2030 Dream Threatened by Tariffs, Regulation

  • Post published:August 23, 2026
  • Post category:News

India's pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed…

Continue Reading Indian Pharma’s $250B 2030 Dream Threatened by Tariffs, Regulation

Understanding CDSCO’s Generic Drug Approval Process in India: A 2026 Buyer’s Guide

  • Post published:August 22, 2026
  • Post category:Knowledge

India is the world's largest producer of generic medicines by volume, supplying over 20% of the global generic drug market. For buyers — whether hospitals, clinics, pharmacies, or individual patients…

Continue Reading Understanding CDSCO’s Generic Drug Approval Process in India: A 2026 Buyer’s Guide

CDSCO Staffing Gap Threatens India’s Pharma Export Ambitions

  • Post published:August 21, 2026
  • Post category:News

India wants to be the "pharmacy of the world" — a $250 billion pharmaceutical export powerhouse supplying affordable generics to every corner of the globe. But a single structural problem…

Continue Reading CDSCO Staffing Gap Threatens India’s Pharma Export Ambitions
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 79
  • Go to the next page

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
    September 1, 2026/
    0 Comments
  • India Pushes for Pharma Market Access in Argentina and Brazil
    August 31, 2026/
    0 Comments
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
    August 30, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
  • India Pushes for Pharma Market Access in Argentina and Brazil
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
  • CBN and PHARMEXCIL Sign MoU on Controlled Substances Exports
  • Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve